Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2
- PMID: 17016658
Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2
Abstract
Platelet-derived growth factor (PDGF) has been known to induce vascular endothelial growth factor (VEGF) expression in human vascular smooth muscle cells (hVSMCs). We previously reported that Erk-1/2 and AP-1 pathways are crucial in the PDGF-induced VEGF expression in hVSMCs . In this study, we investigated the effect of epigallocatechin-3-gallate (EGCG), the major green tea catechin, on the PDGF-induced VEGF expression in hVSMCs and the underlying mechanisms. EGCG were found to inhibit dose-dependently the VEGF expression and activation of PDGF receptor, Erk-1/2 and AP-1 induced by PDGF. In addition, cell free studies demonstrated that EGCG could directly inhibit the Erk-1/2 activity. Conditioned media from the hVSMCs treated with PDGF could remarkably stimulate the in vitro growth of human umbilical vein endothelial cells (HUVECs) but the media from the EGCG-pretreated hVSMCs lost its stimulatory activity for HUVEC proliferation. These results suggest that EGCG may exert the anti-angiogenic effect by inhibiting the PDGF-induced VEGF expression at multiple signaling levels.
Similar articles
-
(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.Chem Biol Interact. 2010 May 14;185(3):247-52. doi: 10.1016/j.cbi.2010.03.036. Epub 2010 Mar 25. Chem Biol Interact. 2010. PMID: 20346928
-
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.Cancer Res. 2006 Mar 1;66(5):2500-5. doi: 10.1158/0008-5472.CAN-05-3636. Cancer Res. 2006. PMID: 16510563 Review.
-
Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells.Int J Oncol. 2006 Jan;28(1):135-41. Int J Oncol. 2006. PMID: 16327989
-
Antiangiogenic properties of natural polyphenols from red wine and green tea.J Nutr Biochem. 2005 Jan;16(1):1-8. doi: 10.1016/j.jnutbio.2004.09.004. J Nutr Biochem. 2005. PMID: 15629234 Review.
-
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.Br J Cancer. 2001 Mar 23;84(6):844-50. doi: 10.1054/bjoc.2000.1691. Br J Cancer. 2001. PMID: 11259102 Free PMC article.
Cited by
-
Preclinical Pharmacological Activities of Epigallocatechin-3-gallate in Signaling Pathways: An Update on Cancer.Molecules. 2020 Jan 22;25(3):467. doi: 10.3390/molecules25030467. Molecules. 2020. PMID: 31979082 Free PMC article. Review.
-
Four-week histologic evaluation of grafted calvarial defects with adjunctive hyperbaric oxygen therapy in rats.J Periodontal Implant Sci. 2016 Aug;46(4):244-53. doi: 10.5051/jpis.2016.46.4.244. Epub 2016 Aug 30. J Periodontal Implant Sci. 2016. PMID: 27588214 Free PMC article.
-
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.J Vasc Surg. 2013 Nov;58(5):1360-5. doi: 10.1016/j.jvs.2012.11.090. Epub 2013 Mar 26. J Vasc Surg. 2013. PMID: 23538007 Free PMC article.
-
Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.Pharmacol Res. 2010 Dec;62(6):457-64. doi: 10.1016/j.phrs.2010.07.010. Epub 2010 Aug 4. Pharmacol Res. 2010. PMID: 20691268 Free PMC article. Review.
-
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.Breast Cancer Res Treat. 2009 Oct;117(3):505-15. doi: 10.1007/s10549-008-0196-x. Epub 2008 Sep 28. Breast Cancer Res Treat. 2009. PMID: 18821062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
